Does prophylaxis against atrial fibrillation after cardiac surgery reduce length of stay or hospital costs?

Pharmacotherapy

Volumn 21, Issue 3 I, 2001, Pages 338-344

  Reddy, P ^a  

^a HARTFORD HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMIODARONE; PLACEBO; SOTALOL;

ANTICOAGULATION; CARDIOVERSION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; ECONOMIC ASPECT; HEART ATRIUM FIBRILLATION; HEART SURGERY; HOSPITAL COST; HUMAN; HUMAN TISSUE; LENGTH OF STAY; META ANALYSIS; RANDOMIZED CONTROLLED TRIAL; SHORT SURVEY;

AMIODARONE; ANTI-ARRHYTHMIA AGENTS; ATRIAL FIBRILLATION; CARDIAC SURGICAL PROCEDURES; COSTS AND COST ANALYSIS; HOSPITALIZATION; HUMANS; LENGTH OF STAY; RANDOMIZED CONTROLLED TRIALS; SOTALOL;

EID: 0035106765     PISSN: 02770008     EISSN: None     Source Type: Journal    
DOI: 10.1592/phco.21.3.338.34199     Document Type: Short Survey

References (23)

1. Ventricular conduction defects and atrial fibrillation after coronary artery bypass grafting. Multivariate analysis of preoperative, intraoperative and postoperative variables
2. Predictors of atrial fibrillation after coronary artery surgery: Current trends and impact on hospital resources
3. Do age and postoperative atrial fibrillation explain temporal trends in mortality and stroke after cardiac surgery?
4. Hazards of postoperative atrial arrhythmias
5. Atrial fibrillation following coronary artery bypass surgery
6. Prevention of postoperative atrial fibrillation: What is the best approach?
7. Determinants of hospital charges for coronary artery bypass surgery: The economic consequences of postoperative complications
8. Atrial fibrillation following coronary artery bypass surgery: Predictors, outcomes, and resource utilization
9. Con: All patients should not receive pharmacologic prophylaxis for atrial fibrillation after cardiac surgery
10. Meta-analysis of the effectiveness of prophylactic drug therapy in preventing supraventricular arrhythmia early after coronary artery bypass grafting
11. Prevention of supraventricular arrhythmias after coronary artery bypass surgery: A meta-analysis of randomized control trials
12. Preoperative amiodarone as prophylaxis against atrial fibrillation after heart surgery
13. Prophylactic oral amiodarone compared with placebo for prevention of atrial fibrillation after coronary artery bypass surgery
14. Intravenous amiodarone for the prevention of atrial fibrillation after open heart surgery: The amiodarone reduction in coronary heart (ARCH) trial
15. Oral amiodarone for the prevention of atrial fibrillation after open heart surgery
16. An economic comparison of amiodarone versus placebo in the prevention of atrial fibrillation after open heart surgery
17. Intravenous amiodarone for prevention of atrial fibrillation after coronary artery bypass grafting
18. Intraoperative amiodarone as prophylaxis against atrial fibrillation after coronary operations
19. Oral d,l-sotalol reduces the incidence of postoperative atrial fibrillation in coronary artery bypass surgery patients: A randomized, double-blind, placebo-controlled study
20. Atrial fibrillation independently prolongs hospital stay after coronary artery bypass surgery
21. Effectiveness of digitalis with or without acebutolol in preventing atrial arrhythmias after coronary artery surgery
22. Selective versus non-selective antiarrhythmic approach for prevention of atrial fibrillation after coronary surgery: Is there a need for preoperative risk stratification?
23. Early discharge of patients with new-onset atrial fibrillation after cardiovascular surgery